drugset / Trial / NCT00314158

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00314158

Phase 3 Completed 523 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2005-11
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule 10 mg/ml Other
Subject Timolol Other / unclassified 5 mg/ml Other